Zenox
From a company announcement 9 February this year:
The median Overall Survival (mOS) for the 56 men in the LuPIN study was 19.7 months, an increase on the 17.1 months reported 12 months ago (ASX announcement: 14 February 2020) at the same conference for the first 32 men in the study.
My Year 9 maths tells me that mOS for the 1200mg cohort from the study is 22.8 months.
Happy for someone to correct my calculation which demonstrates that the actual mOS is higher.
Exquisite Timing, page-17
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
